Identification and validation of susceptibility modules and hub genes in polyarticular juvenile idiopathic arthritis

Junfeng Liu1,2, Jianhui Fan3, Hongxiang Duan4

  • 1Department of Orthopedics, Dazhou Central Hospital, Dazhou, China.

Autoimmunity
|December 19, 2024
PubMed

Insights

This study identified four key genes (PHLDA1, EGR3, CXCL2, PF4V1) associated with juvenile idiopathic arthritis (JIA) progression. These genes show promise as biomarkers for early diagnosis and personalized treatment of JIA.

Area of Science:

  • Immunology
  • Genetics
  • Computational Biology

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic autoimmune childhood disease causing joint inflammation and potential long-term damage.
  • Early identification of prognostic factors is crucial for effective management and preventing joint deterioration.

Purpose of the Study:

  • To identify genes linked to the progression and prognosis of polyarticular JIA.
  • To enhance clinical diagnosis and treatment strategies for JIA patients.

Main Methods:

  • Analysis of the Gene Expression Omnibus (GEO) dataset GSE1402 for differentially expressed genes (DEGs) in JIA polyarticular patients.
  • Application of Weighted Gene Co-expression Network Analysis (WGCNA) and protein-protein interaction (PPI) networks to identify key gene modules and hub genes.
  • Utilized random forest models for biomarker screening and ROC curves for validation, alongside GO and KEGG pathway analysis.

Main Results:

  • Identified PHLDA1, EGR3, CXCL2, and PF4V1 as significantly associated with JIA polyarticular progression and prognosis.
  • These genes demonstrated high diagnostic and prognostic assessment value in the study.
  • Functional enrichment analysis highlighted potential JIA-related pathways.

Conclusions:

  • PHLDA1, EGR3, CXCL2, and PF4V1 serve as potential molecular biomarkers for JIA polyarticular.
  • These biomarkers offer valuable insights for early diagnosis and personalized treatment approaches.
  • Further research can leverage these findings for improved JIA patient outcomes.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.4K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K